2.13
Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This proces…
In type 1 diabetes, genetic and environmental factors contribute to an autoimmune response where the immune system attacks the insulin-producing beta cells in the pancreas.
These beta cells reside in clusters called the islets of Langerhans and are responsible for producing insulin, a hormone that allows glucose to enter cells for energy or storage.
As the autoimmune process unfolds, T helper 1 cells become activated and release inflammatory cytokines, such as interferon-gamma or IFN-γ, and tumor necrosis factor-alpha or TNF-α.
IFN-γ, in particular, activates macrophages and strengthens antigen presentation. These signals allow cytotoxic T cells to attack and destroy beta cells, leading to insulitis, marked by inflammation and beta cell damage in the islets of Langerhans.
Over time, ongoing inflammation progressively destroys the beta cells, drastically reducing or completely eliminating insulin production.
Without enough insulin, glucose cannot enter the body’s cells and begins to accumulate in the bloodstream.
This buildup of blood sugar leads to a condition known as hyperglycemia.
View the full transcript and gain access to JoVE Core videos
Q1: What role do the islets of Langerhans play in type 1 diabetes?
The islets of Langerhans are clusters of cells in the pancreas containing beta cells that produce insulin. In type 1 diabetes, these islets become inflamed through an autoimmune process called insulitis, where immune cells attack and destroy the insulin-producing beta cells, progressively reducing insulin production.
Q2: How do T helper 1 cells contribute to beta cell destruction in type 1 diabetes?
T helper 1 cells become activated against beta cell antigens and release pro-inflammatory cytokines, including interferon-gamma and tumor necrosis factor-alpha. These cytokines activate macrophages, enhance antigen presentation, and enable cytotoxic T cells to attack and destroy beta cells, perpetuating the autoimmune response.
Q3: What is the relationship between insulin deficiency and hyperglycemia in type 1 diabetes?
Insulin is required for glucose uptake into cells for energy or storage. Without sufficient insulin from destroyed beta cells, glucose cannot enter muscle and adipose tissue and accumulates in the bloodstream, causing hyperglycemia. This blood sugar buildup marks the clinical onset of type 1 diabetes.
Q4: How do genetic and environmental factors initiate the autoimmune response in type 1 diabetes?
Type 1 diabetes develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge. Genetic predisposition, including susceptibility alleles within HLA loci, influences autoimmune likelihood, while environmental triggers such as viral infections may precipitate or accelerate beta cell injury.
Q5: What is insulitis and how does it damage pancreatic beta cells?
Insulitis is an inflammatory infiltration of the islets of Langerhans characterized by T cells, macrophages, and other immune effectors. Chronic exposure to cytotoxic mediators from these immune cells leads to apoptosis and progressive depletion of beta cell mass, eventually eliminating insulin production capacity.
Q6: How does interferon-gamma amplify the immune attack on beta cells?
Interferon-gamma, released by activated T helper 1 cells, plays a central role in amplifying the immune response by promoting macrophage activation and enhancing antigen presentation. These enhanced signals allow cytotoxic T cells to more effectively recognize and attack beta cells, intensifying the autoimmune destruction.
Q7: What distinguishes type 1 diabetes from other forms of diabetes mellitus?
Type 1 diabetes results from immune-mediated destruction of pancreatic beta cells, causing absolute insulin deficiency. This contrasts with other diabetes types where insulin production may be preserved but ineffective. Understanding type 1 diabetes pathophysiology helps explain its acute onset and distinct clinical presentation compared to other forms.